Related Experiment Video
Updated: Jul 7, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis
Enrico Fainardi1, Massimiliano Castellazzi, Silva Seraceni
1Dipartimento di Neuroscienze, Unità Operativa di Neuroradiologia, Azienda Ospedaliera Universitaria, Arcispedale S Anna, Ferrara, Italy. henryfai@tin.it
Current Neurovascular Research
|February 22, 2008
Summary
Chlamydia pneumoniae infection may act as a cofactor in a subset of Multiple Sclerosis (MS) patients, potentially causing chronic brain infections. However, evidence does not support its central role in MS pathogenesis.
Area of Science:
- Neuroimmunology
- Infectious Diseases
- Neurology
Background:
- Multiple Sclerosis (MS) is a CNS inflammatory disease with unknown autoimmune etiology.
- Infection, particularly Chlamydia pneumoniae, has been investigated as a potential trigger for MS.
- Existing research presents controversial findings regarding the link between C. pneumoniae and MS.
Purpose of the Study:
- To investigate the role of Chlamydia pneumoniae in the pathogenesis of Multiple Sclerosis.
- To evaluate the association between C. pneumoniae infection markers and MS disease activity.
- To determine if C. pneumoniae could be a causative agent or cofactor in MS development.
Main Methods:
- Analysis of C. pneumoniae presence in cerebrospinal fluid (CSF) and brain tissue using PCR, culture, and immunohistochemistry.
- Detection of intrathecal synthesis of anti-C. pneumoniae IgG.
- Evaluation of seroepidemiological data and animal models of MS.
Main Results:
- Seroepidemiological studies showed no strong association between C. pneumoniae infection and MS risk.
- PCR and isolation techniques yielded inconsistent results for C. pneumoniae in MS patients' CSF and brain.
- A subset of MS patients exhibited C. pneumoniae in CSF, with evidence of intrathecal IgG production and association with disease activity, particularly in progressive forms.
Conclusions:
- Current data do not establish Chlamydia pneumoniae as a primary cause of Multiple Sclerosis.
- C. pneumoniae may act as a cofactor in a subset of MS patients, contributing to chronic brain infection and disease development.
- The precise involvement of C. pneumoniae in MS pathogenesis requires further elucidation.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:29Bacterial Phylum Chlamydiae
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...